Cargando…

1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients

BACKGROUND: The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics us...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae-Hwan, Shin, Ji Seong, Kim, Sin Young, Jang, Min Sik, Kim, Jihye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677349/
http://dx.doi.org/10.1093/ofid/ofad500.1522
_version_ 1785150108626583552
author Kim, Tae-Hwan
Shin, Ji Seong
Kim, Sin Young
Jang, Min Sik
Kim, Jihye
author_facet Kim, Tae-Hwan
Shin, Ji Seong
Kim, Sin Young
Jang, Min Sik
Kim, Jihye
author_sort Kim, Tae-Hwan
collection PubMed
description BACKGROUND: The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics use may be an important etiologic factor. We aimed to assess the association between antibiotics use and the development of KD. METHODS: A population-based, case-control study was performed using data from 2010 to 2019 from the Health Insurance Review and Assessment Service (HIRA) database. Various profiles regarding prior antibiotics use since birth were compared between patients with KD and matched controls. Children aged < 5 years who were diagnosed with initial episode of KD from 2016 to 2019 were identified. Propensity score-matched controls without KD were selected from the general population in a 1:5 ratio. Four separate study cohorts according to four different periods of antibiotics use were created: 1) within 28 days after birth; 2) within 12 months after birth; 3) within 6 months from the index date; and 4) within 12 months from the index date. The occurrence of KD were compared between KD cases and controls. RESULTS: Overall, 17,818 patients with KD and 89,090 matched controls were included in the analysis. Use of antibiotics within 6 months (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.12–1.26) and 12 months (OR, 1.23; 95% CI, 1.14–1.32) from the index date were associated with the development of KD. The association between antibiotics use and KD (OR, 1.26; 95% CI, 1.17–1.37) was most prominent in patients who had received more than three classes of antibiotics within 12 months from the index date. No significant association was observed between the duration of antibiotics use, use of all three major antibiotics classes, or use of any specific antibiotics class and KD. CONCLUSION: The development of KD is associated with antibiotics use. However, evidence suggesting that antibiotics use in the neonatal period or within the first 12 months of life is associated with KD is weak. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677349
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106773492023-11-27 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients Kim, Tae-Hwan Shin, Ji Seong Kim, Sin Young Jang, Min Sik Kim, Jihye Open Forum Infect Dis Abstract BACKGROUND: The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics use may be an important etiologic factor. We aimed to assess the association between antibiotics use and the development of KD. METHODS: A population-based, case-control study was performed using data from 2010 to 2019 from the Health Insurance Review and Assessment Service (HIRA) database. Various profiles regarding prior antibiotics use since birth were compared between patients with KD and matched controls. Children aged < 5 years who were diagnosed with initial episode of KD from 2016 to 2019 were identified. Propensity score-matched controls without KD were selected from the general population in a 1:5 ratio. Four separate study cohorts according to four different periods of antibiotics use were created: 1) within 28 days after birth; 2) within 12 months after birth; 3) within 6 months from the index date; and 4) within 12 months from the index date. The occurrence of KD were compared between KD cases and controls. RESULTS: Overall, 17,818 patients with KD and 89,090 matched controls were included in the analysis. Use of antibiotics within 6 months (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.12–1.26) and 12 months (OR, 1.23; 95% CI, 1.14–1.32) from the index date were associated with the development of KD. The association between antibiotics use and KD (OR, 1.26; 95% CI, 1.17–1.37) was most prominent in patients who had received more than three classes of antibiotics within 12 months from the index date. No significant association was observed between the duration of antibiotics use, use of all three major antibiotics classes, or use of any specific antibiotics class and KD. CONCLUSION: The development of KD is associated with antibiotics use. However, evidence suggesting that antibiotics use in the neonatal period or within the first 12 months of life is associated with KD is weak. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677349/ http://dx.doi.org/10.1093/ofid/ofad500.1522 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Kim, Tae-Hwan
Shin, Ji Seong
Kim, Sin Young
Jang, Min Sik
Kim, Jihye
1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients
title 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients
title_full 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients
title_fullStr 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients
title_full_unstemmed 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients
title_short 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients
title_sort 1689. comparison of antibiotics use between patients with kawasaki disease and propensity score-matched controls: a cohort study of 106,908 patients
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677349/
http://dx.doi.org/10.1093/ofid/ofad500.1522
work_keys_str_mv AT kimtaehwan 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients
AT shinjiseong 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients
AT kimsinyoung 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients
AT jangminsik 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients
AT kimjihye 1689comparisonofantibioticsusebetweenpatientswithkawasakidiseaseandpropensityscorematchedcontrolsacohortstudyof106908patients